Gen-Probe and Life Technologies to Co-Distribute SeCore® HLA Sequence …Equities.comSeCore HLA SBT kits are Life Technologies' latest line of high-resolution human leukocyte antigen (HLA) typing products based on sequence-based typing, the 'g…
Hepatitis can kill 5 million people in next decade: WHO – Indian Express
The NationHepatitis can kill 5 million people in next decade: WHOIndian ExpressOver 5 million people could die of viral hepatitis in the next decade in South-East Asia region, according World Health Organisation (WHO) estimates. The Hepatitis B virus (…
Heartburn pills could increase cancer risk – Times of India
Heartburn pills could increase cancer riskTimes of IndiaIndiatimes|The Times of India|The Economic Times|. More. More …. It suggests that if you take the drug, known as proton pump inhibitors (PPIs), for more than a year – the risks can include infec…
Multi-organ failure claimed in suit against Barnes-Jewish – Madison County Record
Madison County RecordMulti-organ failure claimed in suit against Barnes-JewishMadison County RecordShe says the leakage was not propertly treated and eventually caused "multisystem organ failure." Levine contends she has sustained "const…
Viral hepatitis could kill 5mn in South East Asia: WHO – India.Com Health
Viral hepatitis could kill 5mn in South East Asia: WHOIndia.Com HealthLiver Viral hepatitis may be the reason for over five million people are likely to lose life over the viral hepatitis in Southeast Asia region in the next decade. The World Health Or…
Biogen Idec-Aktie: Gewinn im zweiten Quartal legt zu – boerse.de (Pressemitteilung)
Biogen Idec-Aktie: Gewinn im zweiten Quartal legt zuboerse.de (Pressemitteilung)21.09.10, Biogen Idec mögliche Konkurrenz für Multiple Sklerose-Franchise. 16.09.10, Biogen Idec "equal weight". 29.10.10, Biogen Idec Downgrade. 24.05.10, Biog…
Biogen Idec Increases Revenue 18% to $1.4 Billion in the Second Quarter – PharmaLive (press release) (subscription)
Biogen Idec Increases Revenue 18% to $1.4 Billion in the Second QuarterPharmaLive (press release) (subscription)… global pediatric studies for its long-lasting factor VIII and factor IX programs for hemophilia and completing enrollment in the Phase 3…
Gen-Probe and Life Technologies to Co-Distribute SeCore® HLA Sequence … – MarketWatch (press release)
Gen-Probe and Life Technologies to Co-Distribute SeCore® HLA Sequence …MarketWatch (press release)SeCore HLA SBT kits are Life Technologies' latest line of high-resolution human leukocyte antigen (HLA) typing products based on sequence-based typ…
Gen-Probe and Life Technologies to Co-Distribute SeCore® HLA Sequence … – PR Newswire (press release)
Gen-Probe and Life Technologies to Co-Distribute SeCore® HLA Sequence …PR Newswire (press release)SeCore HLA SBT kits are Life Technologies' latest line of high-resolution human leukocyte antigen (HLA) typing products based on sequence-based typ…
St Jude Medical launch of smaller quadripolar technology in India to treat … – pharmabiz.com
St Jude Medical launch of smaller quadripolar technology in India to treat …pharmabiz.comThe Unify Quadra CRT-D works with the company's Quartet left ventricular pacing lead to offer a smaller quadripolar pacing system that helps physicians effec…